14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.10 $3.59 Wednesday, 1st May 2024 GENE stock ended at $2.36. This is 1.72% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 7.14% from a day low at $2.24 to a day high of $2.40.
90 days $1.80 $3.59
52 weeks $0.520 $3.59

Historical Genetic Technologies Ltd prices

Date Open High Low Close Volume
Feb 03, 2016 $2.19 $2.20 $2.12 $2.13 86 300
Feb 02, 2016 $2.16 $2.26 $2.16 $2.20 81 500
Feb 01, 2016 $2.12 $2.21 $2.12 $2.16 33 300
Jan 29, 2016 $2.14 $2.16 $2.01 $2.15 116 300
Jan 28, 2016 $2.24 $2.28 $2.12 $2.15 124 100
Jan 27, 2016 $2.35 $2.39 $2.11 $2.25 329 800
Jan 26, 2016 $2.39 $2.41 $2.29 $2.34 75 600
Jan 25, 2016 $2.12 $2.37 $2.12 $2.30 213 700
Jan 22, 2016 $2.10 $2.11 $2.00 $2.10 86 600
Jan 21, 2016 $2.00 $2.12 $1.99 $2.04 122 500
Jan 20, 2016 $1.86 $1.99 $1.78 $1.97 184 500
Jan 19, 2016 $1.89 $1.89 $1.80 $1.86 99 000
Jan 15, 2016 $1.84 $1.84 $1.72 $1.80 139 500
Jan 14, 2016 $1.91 $1.95 $1.62 $1.80 401 200
Jan 13, 2016 $2.15 $2.24 $1.92 $1.93 354 800
Jan 12, 2016 $2.20 $2.27 $2.05 $2.11 147 500
Jan 11, 2016 $2.32 $2.39 $2.13 $2.20 367 900
Jan 08, 2016 $2.36 $2.40 $2.24 $2.30 290 900
Jan 07, 2016 $2.45 $2.50 $2.31 $2.33 334 700
Jan 06, 2016 $2.55 $2.57 $2.43 $2.49 156 200
Jan 05, 2016 $2.50 $2.56 $2.47 $2.52 104 300
Click to get the best stock tips daily for free!

About Genetic Technologies Ltd

Genetic Technologies Ltd Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecol... GENE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT